UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044342
Receipt number R000050643
Scientific Title ROAD-AHF
Date of disclosure of the study information 2021/05/28
Last modified on 2023/06/02 13:41:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Reduction of worsening renal function by adding dapagliflozin to manage acute heart failure

Acronym

ROAD-AHF

Scientific Title

ROAD-AHF

Scientific Title:Acronym

ROAD-AHF

Region

Japan


Condition

Condition

acute heart failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

the efficacy of dapagliflozin for patients with acute heart failure

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the rate of worsening renal function

Key secondary outcomes

amounts of furosemide at discharge


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Dapagliflozin
10mg
during hospitalization

Interventions/Control_2

conventional therapy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with acute heart failure.

at least one physical examination, edema or jugular vein distension

Key exclusion criteria

use of inotropic agents
mechanical support

Target sample size

100


Research contact person

Name of lead principal investigator

1st name masami
Middle name
Last name nishino

Organization

Osaka Rosai Hospital

Division name

cardiology

Zip code

591-8025

Address

3069-1 Nagasone-cho, Kita-ku, Sakai-shi, Osaka

TEL

072-252-3561

Email

mnishino@osakah.johas.go.jp


Public contact

Name of contact person

1st name Shodai
Middle name
Last name Kawanami

Organization

Osaka Rosai Hospital

Division name

cardiology

Zip code

591-8025

Address

3069-1 Nagasone-cho, Kita-ku, Sakai-shi, Osaka

TEL

072-252-3561

Homepage URL


Email

junnai-hisho@osakah.johas.go.jp


Sponsor or person

Institute

Osaka Rosai Hospital

Institute

Department

Personal name



Funding Source

Organization

Osaka Rosai Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Rosai Hospital

Address

3069-1 Nagasone-cho, Kita-ku, Sakai-shi, Osaka

Tel

072-252-3561

Email

junnai-hisho@osakah.johas.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 04 Month 01 Day

Date of IRB

2021 Year 03 Month 31 Day

Anticipated trial start date

2021 Year 05 Month 08 Day

Last follow-up date

2023 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 05 Month 26 Day

Last modified on

2023 Year 06 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050643


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name